Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
Provided By GlobeNewswire
Last update: Jan 30, 2025
SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will participate in multiple upcoming healthcare conferences being held in February and March.
Read more at globenewswire.com
